The DOI matches its Crossref record, with a small difference in title or year; 134 of the 134 references it cites were found in a registry or an index.
The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial
Abstract
BACKGROUND: Randomized clinical trials have not yet demonstrated the mortality benefit of smoking cessation. OBJECTIVE: To assess the long-term effect on mortality of a randomly applied smoking cessation program. DESIGN: The Lung Health Study was a randomized clinical trial of smoking cessation. Special intervention participants received the smoking intervention program and were compared with usual care participants. Vital status was followed up to 14.5 years. SETTING: 10 clinical centers in the United States and Canada. PATIENTS: 5887 middle-aged volunteers with asymptomatic airway obstruction. MEASUREMENTS: All-cause mortality and mortality due to cardiovascular disease, lung cancer, and other respiratory disease. INTERVENTION: The intervention was a 10-week smoking cessation program that included a strong physician message and 12 group sessions using behavior modification and nicotine gum, plus either ipratropium or a placebo inhaler. RESULTS: At 5 years, 21.7% of special intervention participants had stopped smoking since study entry compared with 5.4% of usual care participants. After up to 14.5 years of follow-up, 731 patients died: 33% of lung cancer, 22% of cardiovascular disease, 7.8% of respiratory disease other than cancer, and 2.3% of unknown causes. All-cause mortality was significantly lower in the special intervention group than in the usual care group (8.83 per 1000 person-years vs. 10.38 per 1000 person-years; P = 0.03). The hazard ratio for mortality in the usual care group compared with the special intervention group was 1.18 (95% CI, 1.02 to 1.37). Differences in death rates for both lung cancer and cardiovascular disease were greater when death rates were analyzed by smoking habit. LIMITATIONS: Results apply only to individuals with airway obstruction. CONCLUSION: Smoking cessation intervention programs can have a substantial effect on subsequent mortality, even when successful in a minority of participants.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These previous studies suggest that the CALERIE treatment effect of 2–3% slower pace of aging corresponds to a reduction in mortality risk of as much as 10–15%, similar in magnitude to the effect of smoking cessation intervention36.”
From Effect of long-term caloric restriction on DNA methylation measures of biological aging in healthy adults from the CALERIE trial (2023) · cites this paper as [36]
In the citing paper
“Also, evidence from randomized trials supports the beneficial effect of smoking cessation.251,252”
From European Guidelines on cardiovascular disease prevention in clinical practice (version 2012) (2012) · cites this paper as [251]
Citations
Cites
The quality of health care delivered to adults in the United States
McGlynn, E. A., Asch, S. M., Adams, J., Keesey, J., Hicks, J., DeCristofaro, A., & Kerr, E. A. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa022615 · Cited by 5,079
Surgeon Volume and Operative Mortality in the United States
Birkmeyer, J. D., Stukel, T. A., Siewers, A. E., Goodney, P. P., Wennberg, D. E., & Lucas, F. L. (2003) · New England Journal of Medicine · doi:10.1056/nejmsa035205 · Cited by 3,106
Halm, E. A., Lee, C., & Chassin, M. R. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-137-6-200209170-00012 · Cited by 1,704
Wucherpfennig, K. W., & Strominger, J. L. (1995) · Cell · doi:10.1016/0092-8674(95)90348-8 · Cited by 1,534
Type 1 diabetes: new perspectives on disease pathogenesis and treatment
Atkinson, M. A., & Eisenbarth, G. S. (2001) · The Lancet · doi:10.1016/s0140-6736(01)05415-0 · Cited by 1,491
Anthonisen, N. R. (1994) · JAMA · doi:10.1001/jama.1994.03520190043033 · Cited by 1,341
Self-citationChassin, M. R. (1998) · JAMA · doi:10.1001/jama.280.11.1000 · Cited by 1,262
Transglutaminases: Nature’s biological glues
GRIFFIN, M., CASADIO, R., & BERGAMINI, C. M. (2002) · Biochemical Journal · doi:10.1042/bj20021234 · Cited by 1,042
Hole, D. J., Watt, G. C. M., Davey-Smith, G., Hart, C. L., Gillis, C. R., & Hawthorne, V. M. (1996) · BMJ · doi:10.1136/bmj.313.7059.711 · Cited by 911
Predictors of patient satisfaction
Jackson, J. L., Chamberlin, J., & Kroenke, K. (2001) · Social Science & Medicine · doi:10.1016/s0277-9536(00)00164-7 · Cited by 861
Research works printed but not linked: 1
- Islam SS, 1994, Cancer Epidemiol Biomarkers Prev, 3, 289
Cited by
Vestbo, J., Hurd, S. S., Agustí, A. G., Jones, P. W., Vogelmeier, C., Anzueto, A., Barnes, P. J., Fabbri, L. M., Martinez, F. J., Nishimura, M., et al. (2013) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201204-0596pp · Cited by 15,983
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012)
Authors/Task Force Members:, Perk, J., De Backer, G., Gohlke, H., Graham, I., Reiner, Ž., Verschuren, M., Albus, C., Benlian, P., Boysen, G., et al. (2012) · European Heart Journal · doi:10.1093/eurheartj/ehs092 · Cited by 8,490
Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II)
Norgren, L., Hiatt, W. R., Dormandy, J. A., Nehler, M. R., Harris, K. A., & Fowkes, F. G. R. (2007) · Journal of Vascular Surgery · doi:10.1016/j.jvs.2006.12.037 · Cited by 8,191
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice
Visseren, F. L. J., Mach, F., Smulders, Y. M., Carballo, D., Koskinas, K. C., Bäck, M., Benetos, A., Biffi, A., Boavida, J.-M., Capodanno, D., et al. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab484 · Cited by 6,485
Heart Disease and Stroke Statistics—2011 Update: A Report From the American Heart Association
Roger, V. L., Go, A. S., Lloyd-Jones, D. M., Adams, R. J., Berry, J. D., Brown, T. M., Carnethon, M. R., Dai, S., de Simone, G., Ford, E. S., et al. (2011) · Circulation · doi:10.1161/cir.0b013e3182009701 · Cited by 6,149
Metadata
- Authors
- Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group*
- Affiliations
- University of Minnesota (US)
- Venue
- Annals of Internal Medicine
- Publisher
- American College of Physicians
- Published
- 2005-02-15
- Volume
- 142
- Issue
- 4
- Pages
- 233-239
- ISSN
- 0003-4819 (ISSN-L)
- 1539-3704
- OpenAlex
- W1981378561
- Cited by
- 1,237
- References
- 133
- Citations by year
- 2026: 24 · 2025: 28 · 2024: 39 · 2023: 47 · 2022: 40 · 2021: 39 · 2020: 40 · 2019: 42 · 2018: 46 · 2017: 53 · 2016: 67 · 2015: 63 · 2014: 65 · 2013: 63 · 2012: 67
- FWCI
- 49.46
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
- Locations
- Annals of Internal Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5u10hl059275-05)
- National Heart, Lung, and Blood Institute (1U10-HL59275)
- Topics
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Smoking Behavior and Cessation
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Chronic Obstructive Pulmonary Disease (COPD) Research
- Health Sciences › Medicine › Oncology › Global Cancer Incidence and Screening
- Keywords
- smoking cessation, long-term mortality, Lung Health Study, nicotine gum, ipratropium bromide, lung cancer mortality, cardiovascular mortality, respiratory mortality, airway obstruction, middle-aged adults, physician counseling
- MeSH terms
- Smoking Prevention, Behavior Therapy, Bronchodilator Agents, Cause of Death, Female, Follow-Up Studies, Forced Expiratory Volume, Humans, Male, Mortality, Ipratropium, Smoking, Smoking Cessation, Pulmonary Disease, Chronic Obstructive
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial. https://app.cochat.ai/papers/10.7326/0003-4819-142-4-200502150-00005
- The paper
- Anthonisen, N. R., Skeans, M. A., Wise, R. A., Manfreda, J., Kanner, R. E., Connett, J. E., & for the Lung Health Study Research Group*. (2005). The Effects of a Smoking Cessation Intervention on 14.5-Year Mortality: A Randomized Clinical Trial. Annals of Internal Medicine. https://doi.org/10.7326/0003-4819-142-4-200502150-00005
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.